Vibrotactile feedback during walki… for Parkinson's (NCT07308418)
Vibrating shoe increases walking speed
- Trial ID
- NCT07308418
- Official Title
- The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease
- Goal
- Vibrating shoe increases walking speed
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Magnes AG
- Study Type
- INTERVENTIONAL
- Enrollment
- 16 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Vibrotactile feedback during walking
Summary For Families
This trial is testing whether a smart shoe can help people with Parkinson's walk faster and with longer, more regular steps, because slower walking and shorter steps raise fall risk and affect quality of life. The shoe, called NUSHU, is a CE-certified device with sensors and small vibration units that give timed vibrations to the foot during the forward part of each step; participants do two short walking tests, once with vibration and once without, so researchers can compare walking speed, step rate, step length, usability, and safety. Earlier work suggests vibration may change how the feet sense movement, so this low-risk pilot will look for initial signs of benefit and whether people find the shoe safe and easy to use; the tester does not know whether the shoe is vibrating during each walk. The study will enroll 16 adults with a confirmed Parkinson's diagnosis who are at least 18, on stable medication, able to walk 200 meters without stopping, and who understand German, and it excludes people with foot nerve problems, atypical Parkinson's, major other walking disorders, or cognitive issues that would interfere with the tests.
Locations
- Magnes AG, Zurich, Canton of Zurich, Switzerland
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Vibrotactile feedback during walking. This trial is testing whether a smart shoe can help people with Parkinson's walk faster and with longer, more regular steps, because slower walking and shorter steps raise fall risk and affect quality of life. The shoe, called NUSHU, is a CE-certified device with sensors and small vibration units that give timed vibrations to the foot during the forward part of each step; participants do two short walking tests, once with vibration and once without, so researchers can compare walking speed, step rate, step length, usability, and safety. Earlier work suggests vibration may change how the feet sense movement, so this low-risk pilot will look for initial signs of benefit and whether people find the shoe safe and easy to use; the tester does not know whether the shoe is vibrating during each walk. The study will enroll 16 adults with a confirmed Parkinson's diagnosis who are at least 18, on stable medication, able to walk 200 meters without stopping, and who understand German, and it excludes people with foot nerve problems, atypical Parkinson's, major other walking disorders, or cognitive issues that would interfere with the tests.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- How many visits does this trial involve?
- A single 45-minute in-person session
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.